Company / Cash per Share
Phathom Pharmaceuticals, Inc. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.90
FY2025
5-year range
$1.90 / $9.20
FY2021-FY2025
Trend
-63.0%
vs FY2024
Sector context
#110 of 205
Health Care
What the data says
At $1.90, Phathom Pharmaceuticals, Inc.'s cash per share ranks #110 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 8 years, ranging from $0.15 in FY2018 to $21.45 in FY2019.
Based on SEC 10-K filings.
1.90 in FY2025 with a 5-year CAGR of -26.2%.
Declined from $9.20 to $1.90 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -21.8%
- 5-Year CAGR
- -26.2%
- 10-Year CAGR
- -
Sector benchmark
#110 of 205 in Health CareTop 54% of 205This company $1.90 Sector average $67.98
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 63.0% year-over-year.
- Ranks #110 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.90 | -63.0% |
| FY2024 | $5.13 | -44.2% |
| FY2023 | $9.20 | +131.5% |
| FY2022 | $3.97 | -19.8% |
| FY2021 | $4.95 | -42.8% |
| FY2020 | $8.65 | -59.7% |
| FY2019 | $21.45 | +14664.4% |
| FY2018 | $0.15 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026